Rapid estrogen receptor-α activation improves ischemic tolerance in aged female rats through a novel protein kinase Cε -dependent mechanism

Jennifer L. Novotny, Amy M. Simpson, Nanette J. Tomicek, Timothy S. Lancaster, Donna H. Korzick

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

The effects of estrogen deficiency on the loss of cardioprotection with advancing age are complex and poorly understood. A major focus of the current study was to uncover a cardioprotective role for rapid, nongenomic estrogen receptor (ER) signaling in the aged female myocardium. We hypothesized that selective ERα activation in aged females would reduce infarct size in part, through reversal of age-associated reductions in mitochondrial protein kinase Cepsi; (PKCepsi;). Hearts isolated from adult (6 month old) and aged (23-24 months old) female F344 rats with ovaries removed (n = 20 per group) were subjected to ischemia/reperfusion (47 min global ischemia). Rats were injected sc with the ERα agonist propylpyrazole triol (PPT) or vehicle 45 min before heart isolation (5 mu;g/kg). Infarct size was greatest in aged vs. adult ovariectomized rats, significantly reduced by PPT, and the protection reversed by prior administration of the ER inhibitor ICI 182,780 (3 mg/kg). Increased ERα particulate targeting occurred after PPT in conjunction with reversal of age-related reductions in nuclear PKCepsi;, mitochondrial PKCepsi; and pAkt (P < 0.05). PPT also increased mRNA levels for the PKCepsi; anchoring protein, receptor for activated C kinase2 (RACK2; P < 0.05). Our data suggest, for the first time, that selective ERα activation reduces ischemic injury in the aged, estrogen-deficient heart through a mechanism involving non- genomic redistribution of ERα and PKCepsi; activation. A novel feed-forward transcriptional mechanism to potentially enhance PKCepsi;-RACK2 interactions was also observed. Collectively, our findings may provide key insight into developing targeted therapeutic interventions in post- menopausal women to reduce ischemia/reperfusion injury, including selective ERa mimetics.

Original languageEnglish (US)
Pages (from-to)889-896
Number of pages8
JournalEndocrinology
Volume150
Issue number2
DOIs
StatePublished - Feb 1 2009

Fingerprint

Estrogen Receptors
Protein Kinase C
Estrogens
Ischemia
Mitochondrial Proteins
Inbred F344 Rats
Reperfusion Injury
Protein Kinases
Reperfusion
Ovary
Myocardium
Messenger RNA
1,3,5-tris(4-hydroxyphenyl)-4-propyl-1H-pyrazole
Wounds and Injuries

All Science Journal Classification (ASJC) codes

  • Endocrinology

Cite this

Novotny, Jennifer L. ; Simpson, Amy M. ; Tomicek, Nanette J. ; Lancaster, Timothy S. ; Korzick, Donna H. / Rapid estrogen receptor-α activation improves ischemic tolerance in aged female rats through a novel protein kinase Cε -dependent mechanism. In: Endocrinology. 2009 ; Vol. 150, No. 2. pp. 889-896.
@article{479d4f29606748b6abb81345776810c9,
title = "Rapid estrogen receptor-α activation improves ischemic tolerance in aged female rats through a novel protein kinase Cε -dependent mechanism",
abstract = "The effects of estrogen deficiency on the loss of cardioprotection with advancing age are complex and poorly understood. A major focus of the current study was to uncover a cardioprotective role for rapid, nongenomic estrogen receptor (ER) signaling in the aged female myocardium. We hypothesized that selective ERα activation in aged females would reduce infarct size in part, through reversal of age-associated reductions in mitochondrial protein kinase Cepsi; (PKCepsi;). Hearts isolated from adult (6 month old) and aged (23-24 months old) female F344 rats with ovaries removed (n = 20 per group) were subjected to ischemia/reperfusion (47 min global ischemia). Rats were injected sc with the ERα agonist propylpyrazole triol (PPT) or vehicle 45 min before heart isolation (5 mu;g/kg). Infarct size was greatest in aged vs. adult ovariectomized rats, significantly reduced by PPT, and the protection reversed by prior administration of the ER inhibitor ICI 182,780 (3 mg/kg). Increased ERα particulate targeting occurred after PPT in conjunction with reversal of age-related reductions in nuclear PKCepsi;, mitochondrial PKCepsi; and pAkt (P < 0.05). PPT also increased mRNA levels for the PKCepsi; anchoring protein, receptor for activated C kinase2 (RACK2; P < 0.05). Our data suggest, for the first time, that selective ERα activation reduces ischemic injury in the aged, estrogen-deficient heart through a mechanism involving non- genomic redistribution of ERα and PKCepsi; activation. A novel feed-forward transcriptional mechanism to potentially enhance PKCepsi;-RACK2 interactions was also observed. Collectively, our findings may provide key insight into developing targeted therapeutic interventions in post- menopausal women to reduce ischemia/reperfusion injury, including selective ERa mimetics.",
author = "Novotny, {Jennifer L.} and Simpson, {Amy M.} and Tomicek, {Nanette J.} and Lancaster, {Timothy S.} and Korzick, {Donna H.}",
year = "2009",
month = "2",
day = "1",
doi = "10.1210/en.2008-0708",
language = "English (US)",
volume = "150",
pages = "889--896",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "2",

}

Rapid estrogen receptor-α activation improves ischemic tolerance in aged female rats through a novel protein kinase Cε -dependent mechanism. / Novotny, Jennifer L.; Simpson, Amy M.; Tomicek, Nanette J.; Lancaster, Timothy S.; Korzick, Donna H.

In: Endocrinology, Vol. 150, No. 2, 01.02.2009, p. 889-896.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Rapid estrogen receptor-α activation improves ischemic tolerance in aged female rats through a novel protein kinase Cε -dependent mechanism

AU - Novotny, Jennifer L.

AU - Simpson, Amy M.

AU - Tomicek, Nanette J.

AU - Lancaster, Timothy S.

AU - Korzick, Donna H.

PY - 2009/2/1

Y1 - 2009/2/1

N2 - The effects of estrogen deficiency on the loss of cardioprotection with advancing age are complex and poorly understood. A major focus of the current study was to uncover a cardioprotective role for rapid, nongenomic estrogen receptor (ER) signaling in the aged female myocardium. We hypothesized that selective ERα activation in aged females would reduce infarct size in part, through reversal of age-associated reductions in mitochondrial protein kinase Cepsi; (PKCepsi;). Hearts isolated from adult (6 month old) and aged (23-24 months old) female F344 rats with ovaries removed (n = 20 per group) were subjected to ischemia/reperfusion (47 min global ischemia). Rats were injected sc with the ERα agonist propylpyrazole triol (PPT) or vehicle 45 min before heart isolation (5 mu;g/kg). Infarct size was greatest in aged vs. adult ovariectomized rats, significantly reduced by PPT, and the protection reversed by prior administration of the ER inhibitor ICI 182,780 (3 mg/kg). Increased ERα particulate targeting occurred after PPT in conjunction with reversal of age-related reductions in nuclear PKCepsi;, mitochondrial PKCepsi; and pAkt (P < 0.05). PPT also increased mRNA levels for the PKCepsi; anchoring protein, receptor for activated C kinase2 (RACK2; P < 0.05). Our data suggest, for the first time, that selective ERα activation reduces ischemic injury in the aged, estrogen-deficient heart through a mechanism involving non- genomic redistribution of ERα and PKCepsi; activation. A novel feed-forward transcriptional mechanism to potentially enhance PKCepsi;-RACK2 interactions was also observed. Collectively, our findings may provide key insight into developing targeted therapeutic interventions in post- menopausal women to reduce ischemia/reperfusion injury, including selective ERa mimetics.

AB - The effects of estrogen deficiency on the loss of cardioprotection with advancing age are complex and poorly understood. A major focus of the current study was to uncover a cardioprotective role for rapid, nongenomic estrogen receptor (ER) signaling in the aged female myocardium. We hypothesized that selective ERα activation in aged females would reduce infarct size in part, through reversal of age-associated reductions in mitochondrial protein kinase Cepsi; (PKCepsi;). Hearts isolated from adult (6 month old) and aged (23-24 months old) female F344 rats with ovaries removed (n = 20 per group) were subjected to ischemia/reperfusion (47 min global ischemia). Rats were injected sc with the ERα agonist propylpyrazole triol (PPT) or vehicle 45 min before heart isolation (5 mu;g/kg). Infarct size was greatest in aged vs. adult ovariectomized rats, significantly reduced by PPT, and the protection reversed by prior administration of the ER inhibitor ICI 182,780 (3 mg/kg). Increased ERα particulate targeting occurred after PPT in conjunction with reversal of age-related reductions in nuclear PKCepsi;, mitochondrial PKCepsi; and pAkt (P < 0.05). PPT also increased mRNA levels for the PKCepsi; anchoring protein, receptor for activated C kinase2 (RACK2; P < 0.05). Our data suggest, for the first time, that selective ERα activation reduces ischemic injury in the aged, estrogen-deficient heart through a mechanism involving non- genomic redistribution of ERα and PKCepsi; activation. A novel feed-forward transcriptional mechanism to potentially enhance PKCepsi;-RACK2 interactions was also observed. Collectively, our findings may provide key insight into developing targeted therapeutic interventions in post- menopausal women to reduce ischemia/reperfusion injury, including selective ERa mimetics.

UR - http://www.scopus.com/inward/record.url?scp=59649083812&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59649083812&partnerID=8YFLogxK

U2 - 10.1210/en.2008-0708

DO - 10.1210/en.2008-0708

M3 - Article

C2 - 19176323

AN - SCOPUS:59649083812

VL - 150

SP - 889

EP - 896

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 2

ER -